ELUT

$0.00

(

0.00%

)
Quote details

stock

Elutia Inc.

NASDAQ | ELUT

0.61

USD

$0.00

(

0.00%

)

At Close (As of Nov 28, 2025)

$28.74M

Market Cap

-

P/E Ratio

-0.93

EPS

$5.12

52 Week High

$0.58

52 Week Low

HEALTHCARE

Sector

ELUT Chart

Recent Chart
Price Action

ELUT Technicals

Tags:

ELUT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $11M
Total Revenue $24M
Cost Of Revenue $14M
Costof Goods And Services Sold $14M
Operating Income -$36M
Selling General And Administrative $19M
Research And Development $3.8M
Operating Expenses $46M
Investment Income Net -
Net Interest Income -$4.8M
Interest Income -
Interest Expense $4.8M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.5M
Income Before Tax -$54M
Income Tax Expense $7K
Interest And Debt Expense -
Net Income From Continuing Operations -$54M
Comprehensive Income Net Of Tax -
Ebit -$49M
Ebitda -$46M
Net Income -$54M

Revenue & Profitability

Earnings Performance

ELUT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $36M
Total Current Assets $26M
Cash And Cash Equivalents At Carrying Value $13M
Cash And Short Term Investments $13M
Inventory $3.9M
Current Net Receivables $7M
Total Non Current Assets $10M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $8.3M
Intangible Assets Excluding Goodwill $8.3M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $2M
Other Non Current Assets -
Total Liabilities $82M
Total Current Liabilities $38M
Current Accounts Payable $4.1M
Deferred Revenue -
Current Debt -
Short Term Debt $1.7M
Total Non Current Liabilities $45M
Capital Lease Obligations $883K
Long Term Debt $23M
Current Long Term Debt $1.3M
Long Term Debt Noncurrent -
Short Long Term Debt Total $25M
Other Current Liabilities $32M
Other Non Current Liabilities $5.5M
Total Shareholder Equity -$46M
Treasury Stock -
Retained Earnings -$230M
Common Stock $35K
Common Stock Shares Outstanding $29M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$23M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $3.7M
Capital Expenditures $654K
Change In Receivables -
Change In Inventory -$58K
Profit Loss -
Cashflow From Investment -$474K
Cashflow From Financing $17M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$1.2M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$54M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $11M
Total Revenue $24M
Cost Of Revenue $14M
Costof Goods And Services Sold $14M
Operating Income -$36M
Selling General And Administrative $19M
Research And Development $3.8M
Operating Expenses $46M
Investment Income Net -
Net Interest Income -$4.8M
Interest Income -
Interest Expense $4.8M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.5M
Income Before Tax -$54M
Income Tax Expense $7K
Interest And Debt Expense -
Net Income From Continuing Operations -$54M
Comprehensive Income Net Of Tax -
Ebit -$49M
Ebitda -$46M
Net Income -$54M

ELUT News

ELUT Profile

Elutia Inc. Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

Elutia Inc. is a pioneering commercial-stage biotechnology firm based in Silver Spring, Maryland, focused on transforming surgical outcomes through its advanced drug-eluting biomatrix technologies. The company is committed to addressing significant unmet medical needs, aiming to redefine conventional surgical practices and establish itself as a leader within the biopharmaceutical landscape. With a robust pipeline and a strategy firmly rooted in innovation, Elutia is well-positioned for substantial growth and enduring impact on the healthcare industry.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+52.76%
$1.61
VINE
+10.76%
$0.39
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
BITF
+11.80%
$3.46
AMZE
+33.81%
$0.52
YGMZ
-10.00%
$0.11
TLRY
-19.80%
$0.82
ADAP
-15.14%
$0.05
NVDA
-1.41%
$177.70
INTC
+7.72%
$39.65
BYND
-0.98%
$1.01
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+14.79%
$0.28
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
ONMD
+45.07%
$2.06
ASST
+0.88%
$1.14
ITUB
+3.23%
$7.66
PCG
+1.78%
$16.01
INHD
-7.36%
$0.20
AFMD
-34.94%
$0.18
SNAP
+0.39%
$7.64
ADTX
+18.78%
$3.72
CAN
+0.75%
$0.92
NVTS
+3.86%
$8.34
CHR
-4.18%
$0.04
KWM
+11.25%
$0.73
BMNU
+14.89%
$8.64
RIOT
+3.96%
$14.96
GRYP
-10.38%
$1.38
CIFR
+8.28%
$20.73
MODV
-25.22%
$0.43
GPUS
-7.35%
$0.30
TEVA
+5.32%
$26.32
RXRX
+0.91%
$4.41
TSLA
+0.31%
$427.94
KDLY
+7.20%
$0.49
DEFT
+10.43%
$1.53
MARA
+6.70%
$11.85
ONDS
-3.43%
$7.95
WULF
+5.18%
$15.61
GOOGL
-0.34%
$318.85
SAND
-6.04%
$12.12
NIO
+0.64%
$5.49
SMX
+166.32%
$46.34
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
CRCL
+10.93%
$80.58
PLUG
+1.76%
$2.01
BURU
+2.85%
$0.22
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
BTG
+2.92%
$4.60
F
+1.06%
$13.33
SOFI
+2.47%
$29.19
VALE
+0.63%
$12.59
C
+1.31%
$102.50
IREN
+0.12%
$48.51
CRCA
+22.96%
$4.52
IBRX
+10.09%
$2.34
NEHC
+8.33%
$5.07
DVLT
-2.58%
$2.07
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
URBN
+13.54%
$77.56
WIT
-0.37%
$2.69
AMD
+0.90%
$216.17
ZIM
+0.97%
$19.70
CRCG
+20.69%
$2.83
MPW
+2.12%
$5.77
MSTR
+2.25%
$179.60
GOOG
-0.66%
$318.15
AMZN
+1.25%
$232.04
TMC
+10.72%
$6.45
ABVE
+15.58%
$3.04
SNDK
+3.75%
$223.12
NGD
+5.42%
$8.26
VSA
-6.74%
$0.11
PFE
+0.19%
$25.76
RIVN
+4.41%
$16.89
BTBT
+4.31%
$2.42
ACHR
+3.40%
$7.74
CCCS
+0.96%
$7.32
ORCL
-1.74%
$201.38
BB
+1.75%
$4.07
FL
-0.37%
$24.01
APLD
+8.09%
$26.96
AAL
+0.89%
$14.05
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+52.76%
$1.61
VINE
+10.76%
$0.39
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
BITF
+11.80%
$3.46
AMZE
+33.81%
$0.52
YGMZ
-10.00%
$0.11
TLRY
-19.80%
$0.82
ADAP
-15.14%
$0.05
NVDA
-1.41%
$177.70
INTC
+7.72%
$39.65
BYND
-0.98%
$1.01
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+14.79%
$0.28
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
ONMD
+45.07%
$2.06
ASST
+0.88%
$1.14
ITUB
+3.23%
$7.66
PCG
+1.78%
$16.01
INHD
-7.36%
$0.20
AFMD
-34.94%
$0.18
SNAP
+0.39%
$7.64
ADTX
+18.78%
$3.72
CAN
+0.75%
$0.92
NVTS
+3.86%
$8.34
CHR
-4.18%
$0.04
KWM
+11.25%
$0.73
BMNU
+14.89%
$8.64
RIOT
+3.96%
$14.96
GRYP
-10.38%
$1.38
CIFR
+8.28%
$20.73
MODV
-25.22%
$0.43
GPUS
-7.35%
$0.30
TEVA
+5.32%
$26.32
RXRX
+0.91%
$4.41
TSLA
+0.31%
$427.94
KDLY
+7.20%
$0.49
DEFT
+10.43%
$1.53
MARA
+6.70%
$11.85
ONDS
-3.43%
$7.95
WULF
+5.18%
$15.61
GOOGL
-0.34%
$318.85
SAND
-6.04%
$12.12
NIO
+0.64%
$5.49
SMX
+166.32%
$46.34
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
CRCL
+10.93%
$80.58
PLUG
+1.76%
$2.01
BURU
+2.85%
$0.22
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
BTG
+2.92%
$4.60
F
+1.06%
$13.33
SOFI
+2.47%
$29.19
VALE
+0.63%
$12.59
C
+1.31%
$102.50
IREN
+0.12%
$48.51
CRCA
+22.96%
$4.52
IBRX
+10.09%
$2.34
NEHC
+8.33%
$5.07
DVLT
-2.58%
$2.07
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
URBN
+13.54%
$77.56
WIT
-0.37%
$2.69
AMD
+0.90%
$216.17
ZIM
+0.97%
$19.70
CRCG
+20.69%
$2.83
MPW
+2.12%
$5.77
MSTR
+2.25%
$179.60
GOOG
-0.66%
$318.15
AMZN
+1.25%
$232.04
TMC
+10.72%
$6.45
ABVE
+15.58%
$3.04
SNDK
+3.75%
$223.12
NGD
+5.42%
$8.26
VSA
-6.74%
$0.11
PFE
+0.19%
$25.76
RIVN
+4.41%
$16.89
BTBT
+4.31%
$2.42
ACHR
+3.40%
$7.74
CCCS
+0.96%
$7.32
ORCL
-1.74%
$201.38
BB
+1.75%
$4.07
FL
-0.37%
$24.01
APLD
+8.09%
$26.96
AAL
+0.89%
$14.05

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.